Tempest Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q2 2024 | 1 | -$0.36 | -$0.36 | -$0.36 |
| Q3 2024 | 3 | -$0.31 | -$0.20 | -$0.25 |
| Q1 2025 | 2 | -$0.31 | -$0.25 | -$0.28 |
| Q2 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q3 2025 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q4 2025 | 1 | -$0.36 | -$0.36 | -$0.36 |
| Q1 2026 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q2 2026 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q3 2026 | 1 | -$0.55 | -$0.55 | -$0.55 |
| Q4 2026 | 1 | -$0.55 | -$0.55 | -$0.55 |
Tempest Therapeutics, Inc. Earnings Date And Information
Tempest Therapeutics, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.42 earnings per share for the quarter, topping analysts' consensus estimates of $-0.47 by $0.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Tempest Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-1.91 diluted earnings per share) and currently has a price-to-earnings ratio of -0.65. Tempest Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Tempest Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.41 | $0 | $0 | ||
| 08/08/2024 | Q2 2024 | -$0.47 | -$0.42 | 0.05 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.44 | -$0.36 | 0.08 | $0 | |
| 03/19/2024 | Q4 2023 | -$0.38 | -$0.35 | 0.03 | $0 | |
| 11/08/2023 | Q3 2023 | -$0.55 | -$0.48 | 0.07 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.58 | -$0.54 | 0.04 | $0 | |
| 05/10/2023 | Q1 2023 | -$0.66 | -$0.58 | 0.08 | $0 | |
| 03/22/2023 | Q4 2022 | -$0.95 | $0 | |||
| 11/08/2022 | Q3 2022 | -$0.76 | -$0.67 | 0.09 | $0 | |
| 08/15/2022 | Q2 2022 | -$0.92 | -$0.83 | 0.09 | $0 | |
| 05/13/2022 | Q1 2022 | -$1.12 | -$1.23 | -0.11 | $0 | |
| 03/31/2022 | Q4 2021 | -$1.16 | $0 | |||
| 11/10/2021 | Q3 2021 | -$1.05 | -$1.21 | -0.16 | $0 | |
| 08/12/2021 | Q2 2021 | -$0.88 | -$7.63 | -6.75 | $0 | |
| 05/13/2021 | Q1 2021 | -$5.25 | -$0.81 | 4.44 | $0 | |
| 03/29/2021 | Q4 2020 | -$4.67 | $0 | |||
| 11/09/2020 | Q3 2020 | -$6.90 | -$0.82 | 6.08 | $0 | |
| 08/10/2020 | Q2 2020 | -$8.20 | -$0.79 | 7.41 | $0 | |
| 05/08/2020 | Q1 2020 | -$10.00 | -$4.67 | 5.33 | $0 | |
| 03/11/2020 | Q4 2019 | -$13.72 | $0 |
Tempest Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Tempest Therapeutics, Inc.'s earnings date?
Tempest Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
-
Did Tempest Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Tempest Therapeutics, Inc. (:TPST) reported $-0.42 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.47 by $0.05.
-
How can I listen to Tempest Therapeutics, Inc.'s earnings conference call?
The conference call for Tempest Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Tempest Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Tempest Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Tempest Therapeutics, Inc. generate each year?
Tempest Therapeutics, Inc. (:TPST) has a recorded net income of $0. Tempest Therapeutics, Inc. has generated $-1.91 earnings per share over the last four quarters.
-
What is Tempest Therapeutics, Inc.'s price-to-earnings ratio?
Tempest Therapeutics, Inc. (:TPST) has a price-to-earnings ratio of -0.65 and price/earnings-to-growth ratio is -0.15.
